Smith+Nephew Q3 2024 Trading Update Announced
Ticker: SNNUF · Form: 6-K · Filed: Oct 16, 2024 · CIK: 845982
| Field | Detail |
|---|---|
| Company | Smith & Nephew PLC (SNNUF) |
| Form Type | 6-K |
| Filed Date | Oct 16, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $5.5 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings-date, trading-update, medical-technology
TL;DR
SN dropping Q3 results Oct 16th - get ready.
AI Summary
Smith & Nephew plc announced on October 16, 2024, that its third quarter trading report for the period ending September 28, 2024, will be released on October 16, 2024. The company, a global medical technology firm, will provide an update on its performance for the third quarter of 2024.
Why It Matters
This filing provides investors with a specific date for the release of Smith & Nephew's third quarter financial performance, allowing them to anticipate upcoming financial results and strategic updates.
Risk Assessment
Risk Level: low — This is a routine announcement of a future earnings report date, carrying minimal inherent risk.
Key Players & Entities
- Smith & Nephew plc (company) — Registrant
- October 16, 2024 (date) — Filing date and announcement date
- September 28, 2024 (date) — End of third quarter period
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing serves as a report of a foreign private issuer, specifically announcing the timing of Smith+Nephew's third quarter 2024 trading report.
When will Smith & Nephew announce its third quarter 2024 trading report?
Smith & Nephew will announce its third quarter trading report for the period ended September 28, 2024, on October 16, 2024.
What is the company's ticker symbol on the New York Stock Exchange?
The company's ticker symbol on the New York Stock Exchange is SNN.
What is the company's primary business?
Smith & Nephew is a global medical technology company.
Which form does Smith & Nephew indicate it files annually?
Smith & Nephew indicates it files its annual reports under cover of Form 20-F.
Filing Stats: 859 words · 3 min read · ~3 pages · Grade level 15.9 · Accepted 2024-10-16 06:11:47
Key Financial Figures
- $5.5 billion — ies, and generated annual sales of $5.5 billion in 2023. Smith+Nephew is a constit
Filing Documents
- a3174i.htm (6-K) — 24KB
- 0001654954-24-013008.txt ( ) — 25KB
Forward-looking Statements
Forward-looking Statements   This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC's website at ww
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.             Smith & Nephew plc     (Registrant)             Date: October 16, 2024 By: /s/ Helen Barraclough     Helen Barraclough     Company Secretary